Zurcher Kantonalbank (Zurich Cantonalbank) Eagle Pharmaceuticals, Inc. Transaction History

Zurcher Kantonalbank (Zurich Cantonalbank)

$32.8 Billion
Q3 2024

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 08, 2023	SELL	$25.06 - $34.09 $11,753 - $15,988	-469 Reduced 18.58%	2,055 $58,000
Q4 2022 Feb 01, 2023	SELL	$24.98 - $39.77 $2,473 - $3,937	-99 Reduced 3.77%	2,524 $73,000
Q2 2022 Aug 09, 2022	SELL	$41.26 - $51.35 $1,732 - $2,156	-42 Reduced 1.58%	2,623 $117,000
Q1 2022 Apr 21, 2022	BUY	$44.58 - $52.6 $27,193 - $32,086	610 Added 29.68%	2,665 $132,000
Q2 2020 Jul 28, 2020	BUY	$43.24 - $55.02 $47,347 - $60,246	1,095 Added 114.06%	2,055 $99,000
Q2 2018 Aug 06, 2018	BUY	$51.25 - $76.62 $26,086 - $38,999	509 Added 112.86%	960 $73,000
Q3 2017 Nov 08, 2017	BUY	$46.62 - $60.36 $21,025 - $27,222	451	451 $27,000

Others Institutions Holding EGRX

# of Institutions

Shares Held

8.6M

Call Options Held

Put Options Held

100

View Full List

About EAGLE PHARMACEUTICALS, INC.

Ticker EGRX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 13,015,900
Market Cap $7.81M
Description
Eagle Pharmaceuticals, Inc., a pharmaceutical company, focuses on developing and commercializing product candidates to treat diseases of the central nervous system or metabolic critical care, and oncology in the United States. The company offers Ryanodex for malignant hyperthermia; and Belrapzo and Bendeka for chronic lymphocytic leukemia and in...

More about EGRX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Zurcher Kantonalbank (Zurich Cantonalbank), based on Form 13F filings with the SEC.

News

Stay updated on Zurcher Kantonalbank (Zurich Cantonalbank) with notifications on news.

Account